Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0 0.066835871404399 0.0764241398759163
Stock impact report

Dr. Reddy's launches pyrimethamine tablets in U.S. [Seeking Alpha]

Dr. Reddy's Laboratories Ltd (RDY) 
US:NYSE Investor Relations: drreddys.com/investors
Company Research Source: Seeking Alpha
Healthcare Dr. Reddy's launches pyrimethamine tablets in U.S. Mar. 20, 2020 6:44 AM ET | Dr. Reddy's Laboratories L... (RDY) Mamta Mayani Dr. Reddy’s Laboratories (NYSE: launched Pyrimethamine is indicated for the treatment of toxoplasmosis when used conjointly with a sulfonamide, since synergism exists with this combination. The Daraprim brand had U.S. sales of ~$10M for the year ended January 2020, according to IQVIA Health. Dr. Reddy’s Pyrimethamine Tablets USP, are available in 25 mg dose in bottle count sizes of 30 and 100. Click to subscribe to real-time analytics on RDY Now read: Vertex Confirms 20% Revenue Growth Forecast, Presents A Compelling Investment Opportunity » Show less Read more
Impact Snapshot
Event Time:
RDY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for
RDY alerts

from News Quantified
Opt-in for
RDY alerts

from News Quantified